fluorodeoxyglucose f18 has been researched along with incretins in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbour, AM; Davila-Roman, VG; Demopoulos, L; Fang, Z; Fossler, M; Gropler, RJ; Haws, T; Lepore, JJ; Olson, E; Russell, SD | 1 |
| Binderup, T; Curovic, VR; Diaz, LJ; Hansen, TW; Jensen, JK; Kjaer, A; Ripa, RS; Rossing, P; von Scholten, BJ; Zobel, EH | 1 |
2 trial(s) available for fluorodeoxyglucose f18 and incretins
| Article | Year |
|---|---|
Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction.
Topics: Adult; Aged; Carbon Radioisotopes; Chronic Disease; Echocardiography; Exercise Tolerance; Female; Fluorodeoxyglucose F18; Glucagon-Like Peptide 1; Glucose; Heart Failure; Humans; Incretins; Male; Middle Aged; Myocardium; Oxygen Consumption; Positron Emission Tomography Computed Tomography; Quality of Life; Radiopharmaceuticals; Stroke Volume; Walk Test | 2016 |
Effect of Liraglutide on Arterial Inflammation Assessed as [
Topics: Aged; Biomarkers; Blood Glucose; Carotid Artery Diseases; Carotid Intima-Media Thickness; Coronary Angiography; Coronary Artery Disease; Denmark; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incretins; Liraglutide; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Treatment Outcome; Vasculitis | 2021 |